These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11043809)

  • 1. Effectiveness of the Kampo kami-shoyo-san (TJ-24) for tremor of antipsychotic-induced parkinsonism.
    Ishikawa T; Funahashi T; Kudo J
    Psychiatry Clin Neurosci; 2000 Oct; 54(5):579-82. PubMed ID: 11043809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four cases of panic disorder successfully treated with Kampo (Japanese herbal) medicines: Kami-shoyo-san and Hange-koboku-to.
    Mantani N; Hisanaga A; Kogure T; Kita T; Shimada Y; Terasawa K
    Psychiatry Clin Neurosci; 2002 Dec; 56(6):617-20. PubMed ID: 12485303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kami-shoyo-san, Kampo (Japanese traditional medicine), is effective for climacteric syndrome, especially in hormone-replacement-therapy-resistant patients who strongly complain of psychological symptoms.
    Hidaka T; Yonezawa R; Saito S
    J Obstet Gynaecol Res; 2013 Jan; 39(1):223-8. PubMed ID: 22765925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in serum tumor necrosis factor (TNF-alpha) with kami-shoyo-san administration in depressed climacteric patients.
    Ushiroyama T; Ikeda A; Sakuma K; Ueki M
    Am J Chin Med; 2004; 32(4):621-9. PubMed ID: 15481651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Traditional Chinese medicine, Kami-Shoyo-San protects ketamine-induced neurotoxicity in human embryonic stem cell-differentiated neurons through activation of brain-derived neurotrophic factor.
    Li Y; Liu Z; Li J; Wang M
    Neuroreport; 2019 Nov; 30(16):1102-1109. PubMed ID: 31568202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptic-induced parkinsonism and Parkinson's disease: differential diagnosis and treatment.
    Hausner RS
    J Clin Psychiatry; 1983 Jan; 44(1):13-6. PubMed ID: 6130081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Parkinsonism during lithium use].
    Walrave TR; Bulens C
    Tijdschr Psychiatr; 2009; 51(2):123-7. PubMed ID: 19194854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of neuroleptic-induced parkinsonism in psychotic patients receiving adjunctive electroconvulsive therapy.
    Mukherjee S; Debsikdar V
    Convuls Ther; 1994 Mar; 10(1):53-8. PubMed ID: 7914462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethosuximide and tremor in Parkinson's disease: a pilot study.
    Pourcher E; Gomez-Mancilla B; Bédard PJ
    Mov Disord; 1992; 7(2):132-6. PubMed ID: 1350060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inefficacy of propranolol in attenuation of drug-induced parkinsonian tremor.
    Metzer WS; Paige SR; Newton JE
    Mov Disord; 1993; 8(1):43-6. PubMed ID: 8093548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motor and non-motor features of Parkinson's disease that predict persistent drug-induced Parkinsonism.
    Morley JF; Pawlowski SM; Kesari A; Maina I; Pantelyat A; Duda JE
    Parkinsonism Relat Disord; 2014 Jul; 20(7):738-42. PubMed ID: 24742370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-induced parkinsonism: relationship to age at onset of schizophrenia.
    Sandyk R; Kay SR
    Funct Neurol; 1991; 6(2):151-7. PubMed ID: 1680777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kami-shoyo-san ameliorates sociability deficits in ovariectomized mice, a putative female model of autism spectrum disorder, via facilitating dopamine D
    Guo Q; Ebihara K; Fujiwara H; Toume K; Awale S; Araki R; Yabe T; Dong E; Matsumoto K
    J Ethnopharmacol; 2019 May; 236():231-239. PubMed ID: 30862522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients.
    Ghadirian AM; Annable L; Bélanger MC; Chouinard G
    J Clin Psychiatry; 1996 Jan; 57(1):22-8. PubMed ID: 8543543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinson's disease masked by clozapine: a case report.
    Zullino DF; Rodondi PY
    Gen Hosp Psychiatry; 2004; 26(4):333-4. PubMed ID: 15234830
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical effectiveness of the Kampo medicine kamishoyosan for adjunctive treatment of tardive dyskinesia in patients with schizophrenia: a 16-week open trial.
    Lee JG; Shin BS; Lee YC; Park SW; Kim YH
    Psychiatry Clin Neurosci; 2007 Oct; 61(5):509-14. PubMed ID: 17875029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant-like effects of the traditional Chinese medicine kami-shoyo-san in rats.
    Park SW; Kim YK; Lee JG; Kim SH; Kim JM; Yoon JS; Park YK; Lee YK; Kim YH
    Psychiatry Clin Neurosci; 2007 Aug; 61(4):401-6. PubMed ID: 17610665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in neuroleptic-induced movement disorders after a switch to quetiapine in patients with schizophrenia.
    Cortese L; Caligiuri MP; Williams R; Schieldrop P; Manchanda R; Malla A; Harricharan R
    J Clin Psychopharmacol; 2008 Feb; 28(1):69-73. PubMed ID: 18204344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug-induced parkinsonian syndromes: a 10-year experience at a regional center of pharmaco-vigilance].
    Llau ME; Nguyen L; Senard JM; Rascol O; Montastruc JL
    Rev Neurol (Paris); 1994 Nov; 150(11):757-62. PubMed ID: 7597368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yi-gan san as adjunctive therapy for treatment-resistant schizophrenia: an open-label study.
    Miyaoka T; Furuya M; Yasuda H; Hayashida M; Nishida A; Inagaki T; Horiguchi J
    Clin Neuropharmacol; 2009; 32(1):6-9. PubMed ID: 19471183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.